A detailed history of Vanguard Group Inc transactions in Veru Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 6,200,728 shares of VERU stock, worth $3.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,200,728
Previous 6,112,563 1.44%
Holding current value
$3.91 Million
Previous $5.13 Million 7.01%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.77 - $1.04 $67,887 - $91,691
88,165 Added 1.44%
6,200,728 $4.77 Million
Q2 2024

Aug 13, 2024

BUY
$0.76 - $1.79 $1.06 Million - $2.5 Million
1,394,655 Added 29.56%
6,112,563 $5.13 Million
Q1 2024

May 10, 2024

BUY
$0.37 - $0.72 $2,971 - $5,783
8,032 Added 0.17%
4,717,908 $3.3 Million
Q4 2023

Feb 14, 2024

BUY
$0.67 - $1.17 $784,592 - $1.37 Million
1,171,033 Added 33.09%
4,709,876 $3.39 Million
Q3 2023

Nov 14, 2023

BUY
$0.72 - $1.33 $7,094 - $13,105
9,854 Added 0.28%
3,538,843 $2.55 Million
Q2 2023

Aug 14, 2023

SELL
$0.98 - $1.49 $421,992 - $641,601
-430,605 Reduced 10.87%
3,528,989 $4.2 Million
Q1 2023

May 15, 2023

SELL
$1.16 - $6.41 $15,178 - $83,874
-13,085 Reduced 0.33%
3,959,594 $4.59 Million
Q4 2022

Feb 10, 2023

BUY
$4.78 - $15.01 $4.12 Million - $12.9 Million
861,786 Added 27.7%
3,972,679 $21 Million
Q3 2022

Nov 14, 2022

SELL
$10.22 - $23.7 $334,183 - $774,966
-32,699 Reduced 1.04%
3,110,893 $35.8 Million
Q2 2022

Aug 12, 2022

SELL
$4.35 - $15.85 $24,768 - $90,249
-5,694 Reduced 0.18%
3,143,592 $35.5 Million
Q1 2022

May 13, 2022

BUY
$4.55 - $6.41 $545,504 - $768,501
119,891 Added 3.96%
3,149,286 $15.2 Million
Q4 2021

Feb 14, 2022

BUY
$5.89 - $9.73 $35,716 - $59,002
6,064 Added 0.2%
3,029,395 $17.8 Million
Q3 2021

Nov 12, 2021

SELL
$6.78 - $9.89 $442,313 - $645,203
-65,238 Reduced 2.11%
3,023,331 $25.8 Million
Q2 2021

Aug 13, 2021

BUY
$7.24 - $11.2 $22.4 Million - $34.6 Million
3,088,569 New
3,088,569 $24.9 Million

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $50.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.